You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsed/Refractory B-NHL

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SALVAGE TREATMENT WITH GLOFITAMAB IN RELAPSED/REFRACTORY B-NHL:

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • +2 more
    • (no location specified)
    Jun 22, 2023

    NHL, NHL, Relapsed, Adult Trial in United States (CLN-978)

    Recruiting
    • NHL
    • NHL, Relapsed, Adult
    • Birmingham, Alabama
    • +4 more
    May 31, 2023

    Relapsed or Refractory Mantle Cell Lymphoma (MCL) Trial in Duarte (BAFFR-CAR T cells)

    Recruiting
    • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    • BAFFR-CAR T cells
    • Duarte, California
      City of Hope Medical Center
    Oct 18, 2022

    Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Trial (C-CAR066)

    Not yet recruiting
    • Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
    • (no location specified)
    Mar 23, 2023

    B-cell NHL, CLL Trial (CARCIK-CD19)

    Not yet recruiting
    • B-cell NHL
    • CLL
    • CARCIK-CD19
    • (no location specified)
    May 19, 2023

    Lymphoma, Non-Hodgkin Trial in Perth (DZD8586)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin
    • Perth, Western Australia, Australia
      Linear Clinical Research Ltd
    Apr 20, 2023

    Auto/Allo Tandem Transplant for Relapsed B-NHL

    Completed
    • Non Hodgkin Lymphoma
    • auto transplant followed by allo transplant
    • (no location specified)
    Oct 24, 2022

    B-cell Non-Hodgkin Lymphoma (B-NHL) Trial in Austin (UCART20x22, CLLS52)

    Recruiting
    • B-cell Non-Hodgkin Lymphoma (B-NHL)
    • UCART20x22
    • CLLS52
    • Austin, Texas
      Sarah Cannon - St. David South Austin Medical Center
    Dec 8, 2022

    Lymphoma, Non-Hodgkin Trial in China (DZD8586)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Beijing, Beijing, China
    • +5 more
    Apr 25, 2023

    Diffuse Large B Cell Lymphoma Trial in Shanghai (BTK inhibitor, PD-1 inhibitor)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • BTK inhibitor
    • PD-1 inhibitor
    • Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    May 20, 2023

    Non-Hodgkin's Lymphoma Trial (MBS303)

    Not yet recruiting
    • Non-Hodgkin's Lymphoma
    • (no location specified)
    Apr 6, 2023

    Relapsed or Refractory Non-Hodgkin's Lymphoma Trial in Changsha, Suzhou (U16)

    Recruiting
    • Relapsed or Refractory Non-Hodgkin's Lymphoma
    • Changsha, Hunan, China
    • +1 more
    Mar 13, 2023

    Non Hodgkin Lymphoma Trial in Aurora (UCD19 CAR T Cells)

    Active, not recruiting
    • Non Hodgkin Lymphoma
    • UCD19 CAR T Cells
    • Aurora, Colorado
      University of Colorado Hospital
    Sep 1, 2022

    LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational

    Not yet recruiting
    • Relapsed Non-Hodgkin Lymphoma
      • (no location specified)
      Sep 19, 2023

      B-cell Non Hodgkin Lymphoma Trial in Hanzhou (anti-CD19 CAR-NK)

      Not yet recruiting
      • B-cell Non Hodgkin Lymphoma
      • anti-CD19 CAR-NK
      • Hanzhou, Zhejiang, China
        2nd Affiliated Hospital, School of Medicine, Zhejiang University
      Jul 21, 2022

      B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Lymphoma (B-ALL) Trial (PIT565)

      Not yet recruiting
      • B-cell Non-Hodgkin Lymphoma (B-NHL)
      • B-cell Acute Lymphoblastic Lymphoma (B-ALL)
      • PIT565
      • (no location specified)
      Jun 13, 2022

      Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +5 more
      • CD19 specific Chimeric Antigen Receptor T Cell
      • Columbus, Ohio
        Nationwide Children's Hospital
      Mar 9, 2023

      B-cell Non-Hodgkin's Lymphoma Trial in Cincinnati (IMM0306)

      Recruiting
      • B-cell Non-Hodgkin's Lymphoma
      • Cincinnati, Ohio
        The Christ Hospital
      Apr 1, 2022

      Follicular B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Recurrent, Mantle Cell Lymphoma Refractory Trial in Orange,

      Recruiting
      • Follicular B-cell Non-Hodgkin's Lymphoma
      • +7 more
      • MB-106
      • Orange, California
      • +3 more
      Nov 1, 2022

      Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited, r/r B-NHL Trial (ThisCART19A)

      Not yet recruiting
      • Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited, r/r B-NHL
      • (no location specified)
      Sep 9, 2022

      B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

      Not yet recruiting
      • B-cell Non Hodgkin Lymphoma
      • Chronic Lymphocytic Leukemia
      • Cyclophosphamide injection
      • +2 more
      • Charleston, South Carolina
        Hollings Cancer Center at Medical University of South Carolina
      Jan 18, 2023

      NHL, Relapsed, Adult, B-cell Lymphoma, B-cell Leukemia Trial (KUR-502)

      Not yet recruiting
      • NHL, Relapsed, Adult
      • +3 more
      • KUR-502
      • (no location specified)
      Aug 2, 2022

      Aggressive B-Cell Non-Hodgkin's Lymphoma, Aggressive B-Cell NHL, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial

      Not yet recruiting
      • Aggressive B-Cell Non-Hodgkin's Lymphoma
      • +4 more
      • (no location specified)
      Dec 16, 2022

      B-cell Non-Hodgkin's Lymphoma Trial in Hangzhou (CD19-CAR-DNT cells)

      Recruiting
      • B-cell Non-Hodgkin's Lymphoma
      • CD19-CAR-DNT cells
      • Hangzhou, Zhejiang, China
        2nd Affiliated Hospital, School of Medicine, Zhejiang University
      Jul 6, 2022

      Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, DLBCL Trial in United States (KT-413)

      Recruiting
      • Non Hodgkin Lymphoma
      • +3 more
      • Washington, District of Columbia
      • +5 more
      Nov 29, 2022